Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Texas Instruments (TXN) Financials

Texas Instruments logo
$206.06 +5.35 (+2.67%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$206.27 +0.21 (+0.10%)
As of 08/22/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Texas Instruments

Annual Income Statements for Texas Instruments

This table shows Texas Instruments' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 2,778 2,944 3,551 3,649 5,538 4,986 5,568 7,736 8,710 6,477 4,775
Consolidated Net Income / (Loss)		 2,821 2,986 3,595 3,682 5,580 5,017 5,595 7,769 8,749 6,510 4,799
Net Income / (Loss) Continuing Operations		 2,821 2,986 3,595 3,682 5,580 5,017 5,595 7,769 8,749 6,510 4,799
Total Pre-Tax Income 		3,874 4,216 4,930 6,080 6,686 5,728 6,017 8,919 10,032 7,418 5,453
Total Operating Income		 3,947 4,322 4,855 6,083 6,713 5,723 5,894 8,960 10,140 7,331 5,465
Total Gross Profit		 7,427 7,575 8,257 9,614 10,277 9,164 9,269 12,376 13,771 11,019 9,094
Total Revenue		 13,045 13,000 13,370 14,961 15,784 14,383 14,461 18,344 20,028 17,519 15,641
Operating Revenue		 13,045 13,000 13,370 14,961 15,784 14,383 14,461 18,344 20,028 17,519 15,641
Total Cost of Revenue		 5,618 5,425 5,113 5,347 5,507 5,219 5,192 5,968 6,257 6,500 6,547
Operating Cost of Revenue		 5,618 5,425 5,113 5,347 5,507 5,219 5,192 5,968 6,257 6,500 6,547
Total Operating Expenses		 3,480 3,253 3,402 3,531 3,564 3,441 3,375 3,416 3,631 3,688 3,629
Selling, General & Admin Expense		 1,843 1,728 1,742 1,694 1,684 1,645 1,647 1,720 1,704 1,825 1,794
Research & Development Expense		 1,358 1,267 1,356 1,508 1,559 1,544 1,530 1,554 1,670 1,863 1,959
Restructuring Charge		 279 258 304 329 321 -36 - - 257 0.00 -124
Total Other Income / (Expense), net		 -73 -106 75 -3.00 -27 5.00 123 -41 -108 87 -12
Interest Expense		 94 90 80 78 125 170 190 184 214 353 508
Other Income / (Expense), net		 21 -16 155 75 98 175 313 143 106 440 496
Income Tax Expense		 1,053 1,230 1,335 2,398 1,106 711 422 1,150 1,283 908 654
Preferred Stock Dividends Declared		 43 42 44 33 42 31 27 33 39 33 24
Basic Earnings per Share		 $2.61 $2.86 $3.54 $3.68 $5.71 $5.33 $6.05 $8.38 $9.51 $7.13 $5.24
Weighted Average Basic Shares Outstanding		 1.07B 1.03B 1.00B 991M 970M 936M 921M 923M 916M 908M 912M
Diluted Earnings per Share		 $2.57 $2.82 $3.48 $3.61 $5.59 $5.24 $5.97 $8.26 $9.41 $7.07 $5.20
Weighted Average Diluted Shares Outstanding		 1.08B 1.04B 1.02B 1.01B 990M 952M 933M 936M 926M 916M 919M
Weighted Average Basic & Diluted Shares Outstanding		 1.05B 1.01B 1.00B 991.60M 969.90M 933.98M 920.24M 923.55M 906.21M 909.29M 910.33M
Cash Dividends to Common per Share		 $1.24 $1.40 - $2.12 $2.63 $3.21 $3.72 $4.21 $4.69 $5.02 $5.26

Quarterly Income Statements for Texas Instruments

This table shows Texas Instruments' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders		 1,953 1,699 1,714 1,699 1,365 1,100 1,121 1,355 1,199 1,173 1,288
Consolidated Net Income / (Loss)		 1,962 1,708 1,722 1,709 1,371 1,105 1,127 1,362 1,205 1,179 1,295
Net Income / (Loss) Continuing Operations		 1,962 1,708 1,722 1,709 1,371 1,105 1,127 1,362 1,205 1,179 1,295
Total Pre-Tax Income 		2,167 1,946 2,002 1,922 1,548 1,293 1,247 1,554 1,359 1,276 1,478
Total Operating Income		 2,176 1,934 1,972 1,892 1,533 1,286 1,248 1,554 1,377 1,324 1,563
Total Gross Profit		 3,087 2,863 2,910 2,815 2,431 2,095 2,211 2,474 2,314 2,313 2,575
Total Revenue		 4,670 4,379 4,531 4,532 4,077 3,661 3,822 4,151 4,007 4,069 4,448
Operating Revenue		 4,670 4,379 4,531 4,532 4,077 3,661 3,822 4,151 4,007 4,069 4,448
Total Cost of Revenue		 1,583 1,516 1,621 1,717 1,646 1,566 1,611 1,677 1,693 1,756 1,873
Operating Cost of Revenue		 1,583 1,516 1,621 1,717 1,646 1,566 1,611 1,677 1,693 1,756 1,873
Total Operating Expenses		 911 929 938 923 898 809 963 920 937 989 1,012
Selling, General & Admin Expense		 220 474 461 452 438 455 465 428 446 472 485
Research & Development Expense		 434 455 477 471 460 478 498 492 491 517 527
Restructuring Charge		 - - 0.00 0.00 - -124 0.00 0.00 - 0.00 0.00
Total Other Income / (Expense), net		 -9.00 12 30 30 15 7.00 -1.00 0.00 -18 -48 -85
Interest Expense		 60 68 89 98 98 116 131 131 130 128 133
Other Income / (Expense), net		 51 80 119 128 113 123 130 131 112 80 48
Income Tax Expense		 205 238 280 213 177 188 120 192 154 97 183
Preferred Stock Dividends Declared		 9.00 9.00 8.00 10 6.00 5.00 6.00 7.00 6.00 6.00 7.00
Basic Earnings per Share		 $2.16 $1.87 $1.89 $1.87 $1.50 $1.21 $1.23 $1.48 $1.32 $1.29 $1.42
Weighted Average Basic Shares Outstanding		 916M 907M 908M 908M 908M 910M 912M 913M 912M 910M 908M
Diluted Earnings per Share		 $2.14 $1.85 $1.87 $1.85 $1.50 $1.20 $1.22 $1.47 $1.31 $1.28 $1.41
Weighted Average Diluted Shares Outstanding		 926M 916M 916M 916M 916M 917M 919M 920M 919M 916M 912M
Weighted Average Basic & Diluted Shares Outstanding		 906.21M 907.65M 907.97M 908.20M 909.29M 910.48M 913.05M 912.22M 910.33M 908.47M 909.14M
Cash Dividends to Common per Share		 - $1.24 $1.24 $1.24 - $1.30 $1.30 $1.30 - $1.36 $1.36

Annual Cash Flow Statements for Texas Instruments

This table details how cash moves in and out of Texas Instruments' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -428 -199 154 502 782 -1.00 670 1,524 -1,581 -86 236
Net Cash From Operating Activities		 4,054 4,397 4,614 5,363 7,189 6,649 6,139 8,756 8,720 6,420 6,318
Net Cash From Continuing Operating Activities		 4,054 4,397 4,614 5,366 7,189 6,649 6,139 8,756 8,720 6,420 6,318
Net Income / (Loss) Continuing Operations		 2,821 2,986 3,595 3,682 5,580 5,017 5,595 7,769 8,749 6,510 4,799
Consolidated Net Income / (Loss)		 2,821 2,986 3,595 3,682 5,580 5,017 5,595 7,769 8,749 6,510 4,799
Depreciation Expense		 850 766 605 539 590 708 733 755 925 1,175 1,508
Amortization Expense		 380 367 350 365 364 342 259 199 54 63 72
Non-Cash Adjustments To Reconcile Net Income		 204 201 212 242 229 194 220 173 286 362 260
Changes in Operating Assets and Liabilities, net		 -201 100 -148 538 426 388 -668 -140 -1,294 -1,690 -321
Net Cash From Investing Activities		 -377 -302 -650 -1,127 -78 -1,920 -922 -4,095 -3,583 -4,362 -3,202
Net Cash From Continuing Investing Activities		 -377 -302 -650 -1,127 -78 -1,920 -922 -4,095 -3,583 -4,362 -3,202
Purchase of Property, Plant & Equipment		 -385 -551 -531 -695 -1,131 -847 -649 -2,462 -2,797 -5,071 -4,820
Purchase of Investments		 -3,107 -2,767 -3,503 -4,555 -5,641 -3,444 -5,786 -10,124 -14,483 -12,705 -9,716
Sale of Property, Plant & Equipment		 142 110 0.00 40 9.00 30 4.00 75 3.00 3.00 195
Sale and/or Maturity of Investments		 2,966 2,892 3,390 4,095 6,708 2,309 5,545 8,478 13,657 13,387 11,187
Other Investing Activities, net		 7.00 14 -6.00 -12 -23 32 -36 -62 37 24 -48
Net Cash From Financing Activities		 -4,105 -4,294 -3,810 -3,734 -6,329 -4,730 -4,547 -3,137 -6,718 -2,144 -2,880
Net Cash From Continuing Financing Activities		 -4,105 -4,294 -3,810 -3,734 -6,329 -4,730 -4,547 -3,137 -6,718 -2,144 -2,880
Repayment of Debt		 -1,003 -1,003 -1,003 -656 -547 -792 -536 -596 -541 -557 -653
Repurchase of Common Equity		 -2,831 -2,741 -2,132 -2,556 -5,100 -2,960 -2,553 -527 -3,615 -293 -929
Payment of Dividends		 -1,323 -1,444 -1,646 -2,104 -2,555 -3,008 -3,426 -3,886 -4,297 -4,557 -4,795
Issuance of Debt		 498 498 499 1,099 1,500 1,491 1,498 1,495 1,494 3,000 2,980
Issuance of Common Equity		 554 396 472 483 373 539 470 377 241 263 517

Quarterly Cash Flow Statements for Texas Instruments

This table details how cash moves in and out of Texas Instruments' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Change in Cash & Equivalents		 -119 1,427 -1,038 -873 398 -481 257 -151 611 -437 281
Net Cash From Operating Activities		 2,042 1,160 1,399 1,937 1,924 1,017 1,571 1,732 1,998 849 1,860
Net Cash From Continuing Operating Activities		 2,042 1,160 1,399 1,937 1,924 1,017 1,571 1,732 1,998 849 1,860
Net Income / (Loss) Continuing Operations		 1,962 1,708 1,722 1,709 1,371 1,105 1,127 1,362 1,205 1,179 1,295
Consolidated Net Income / (Loss)		 1,962 1,708 1,722 1,709 1,371 1,105 1,127 1,362 1,205 1,179 1,295
Depreciation Expense		 249 265 285 303 322 346 363 383 416 424 460
Amortization Expense		 14 16 15 17 15 16 18 19 19 20 21
Non-Cash Adjustments To Reconcile Net Income		 62 104 110 79 69 -23 119 87 77 116 129
Changes in Operating Assets and Liabilities, net		 -245 -933 -733 -171 147 -427 -56 -119 281 -890 -45
Net Cash From Investing Activities		 -1,027 28 -2,385 -1,694 -311 -3,329 - -487 614 1,253 -1,335
Net Cash From Continuing Investing Activities		 -1,027 28 -2,385 -1,694 -311 -3,329 - -487 614 1,253 -1,335
Purchase of Property, Plant & Equipment		 -967 -982 -1,446 -1,495 -1,148 -1,248 -1,064 -1,316 -1,192 -1,123 -1,305
Purchase of Investments		 -3,688 -3,013 -4,047 -3,080 -2,565 -4,864 -2,098 -1,845 -909 -647 -1,192
Sale and/or Maturity of Investments		 3,650 4,026 3,065 2,885 3,411 2,631 3,130 2,700 2,726 2,807 1,131
Other Investing Activities, net		 -22 -4.00 42 -5.00 -9.00 -40 30 -26 -12 216 31
Net Cash From Financing Activities		 -1,134 239 -52 -1,116 -1,215 1,831 -1,314 -1,396 -2,001 -2,539 -244
Net Cash From Continuing Financing Activities		 -1,134 239 -52 -1,116 -1,215 1,831 -1,314 -1,396 -2,001 -2,539 -244
Repayment of Debt		 -12 -15 -516 -12 -14 -28 -306 -8.00 -311 -766 -21
Repurchase of Common Equity		 -848 -103 -79 -46 -65 -3.00 -71 -318 -537 -653 -302
Payment of Dividends		 -1,123 -1,125 -1,125 -1,126 -1,181 -1,183 -1,185 -1,187 -1,240 -1,238 -1,235
Issuance of Debt		 799 1,397 1,603 - - 2,980 - - - 0.00 1,199
Issuance of Common Equity		 50 85 65 68 45 65 248 117 87 118 115

Annual Balance Sheets for Texas Instruments

This table presents Texas Instruments' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 17,372 16,230 16,431 17,642 17,137 18,018 19,351 24,676 27,207 32,348 35,509
Total Current Assets		 7,421 7,074 7,457 8,734 8,097 8,761 10,239 13,685 14,021 15,122 15,026
Cash & Equivalents		 1,199 1,000 1,154 1,656 2,438 2,437 3,107 4,631 3,050 2,964 3,200
Short-Term Investments		 2,342 2,218 2,336 2,813 1,795 2,950 3,461 5,108 6,017 5,611 4,380
Accounts Receivable		 1,246 1,165 1,267 1,278 1,207 1,074 1,414 1,701 1,895 1,787 1,719
Inventories, net		 1,784 1,691 1,790 1,957 2,217 2,001 1,955 1,910 2,757 3,999 4,527
Prepaid Expenses		 850 1,000 910 1,030 440 299 302 335 302 761 1,200
Plant, Property, & Equipment, net		 2,840 2,596 2,512 2,664 3,183 3,303 3,269 5,141 6,876 9,999 11,347
Plant, Property & Equipment, gross		 6,266 5,465 4,923 4,789 5,425 5,740 5,781 7,858 9,950 13,268 15,254
Accumulated Depreciation		 3,426 2,869 2,411 2,125 2,242 2,437 2,512 2,717 3,074 3,269 3,907
Total Noncurrent Assets		 7,111 6,560 6,462 6,244 5,857 5,954 5,843 5,850 6,310 7,227 9,136
Goodwill		 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362
Intangible Assets		 1,985 1,629 1,316 1,056 717 409 122 85 152 223 257
Noncurrent Deferred & Refundable Income Taxes		 180 201 374 264 295 197 343 263 473 757 936
Employee Benefit Assets		 127 85 96 208 92 218 246 392 188 173 233
Other Noncurrent Operating Assets		 233 62 79 86 140 468 770 748 1,135 1,712 3,348
Total Liabilities & Shareholders' Equity		 17,372 16,230 16,431 17,642 17,137 18,018 19,351 24,676 27,207 32,348 35,509
Total Liabilities		 6,982 6,284 5,958 7,305 8,143 9,111 10,164 11,343 12,630 15,451 18,606
Total Current Liabilities		 2,658 2,555 2,264 2,258 2,474 2,123 2,390 2,569 2,985 3,320 3,643
Short-Term Debt		 1,001 1,000 631 500 749 500 550 500 500 599 750
Accounts Payable		 437 386 396 466 478 388 415 571 851 802 820
Current Deferred & Payable Income Tax Liabilities		 71 95 83 128 103 46 134 121 189 172 159
Current Employee Benefit Liabilities		 651 664 710 722 724 714 767 775 799 836 839
Other Current Liabilities		 498 410 444 442 420 475 524 602 646 911 1,075
Total Noncurrent Liabilities		 4,324 3,729 3,694 5,047 5,669 6,988 7,774 8,774 9,645 12,131 14,963
Long-Term Debt		 3,630 3,120 2,978 3,577 4,319 5,303 6,248 7,241 8,235 10,624 12,846
Noncurrent Deferred & Payable Income Tax Liabilities		 64 37 33 78 42 78 90 87 66 63 53
Noncurrent Employee Benefit Liabilities		 225 196 129 89 118 93 131 79 118 108 110
Other Noncurrent Operating Liabilities		 - - 554 1,303 1,190 1,514 1,305 1,367 1,226 1,336 1,954
Total Equity & Noncontrolling Interests		 10,390 9,946 10,473 10,337 8,994 8,907 9,187 13,333 14,577 16,897 16,903
Total Preferred & Common Equity		 10,390 9,946 10,473 10,337 8,994 8,907 9,187 13,333 14,577 16,897 16,903
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 10,390 9,946 10,473 10,337 8,994 8,907 9,187 13,333 14,577 16,897 16,903
Common Stock		 3,109 3,370 3,415 3,517 3,691 3,851 4,074 4,371 4,692 5,103 5,676
Retained Earnings		 29,653 31,176 33,107 34,662 37,906 39,898 42,051 45,919 50,353 52,283 52,262
Treasury Stock		 -21,840 -24,068 -25,523 -27,458 -32,130 -34,495 -36,578 -36,800 -40,214 -40,284 -40,895
Accumulated Other Comprehensive Income / (Loss)		 -532 -532 -526 -384 -473 -347 -360 -157 -254 -205 -140

Quarterly Balance Sheets for Texas Instruments

This table presents Texas Instruments' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Total Assets		 27,207 29,220 30,939 31,638 32,348 34,885 35,048 35,321 35,509 33,757 34,933
Total Current Assets		 14,021 15,023 15,514 15,097 15,122 17,448 16,789 15,872 15,026 13,086 14,484
Cash & Equivalents		 3,050 4,477 3,439 2,566 2,964 2,483 2,740 2,589 3,200 2,763 3,044
Short-Term Investments		 6,017 5,068 6,113 6,382 5,611 7,910 6,948 6,163 4,380 2,242 2,315
Accounts Receivable		 1,895 1,877 1,956 1,976 1,787 1,671 1,711 1,862 1,719 1,860 1,934
Inventories, net		 2,757 3,288 3,729 3,908 3,999 4,083 4,106 4,296 4,527 4,687 4,812
Prepaid Expenses		 302 313 277 265 761 1,301 1,284 962 1,200 1,534 2,379
Plant, Property, & Equipment, net		 6,876 7,665 8,525 9,320 9,999 10,442 11,174 11,802 11,347 11,811 12,321
Plant, Property & Equipment, gross		 9,950 10,791 11,664 12,528 13,268 13,739 14,622 15,464 15,254 16,036 16,878
Accumulated Depreciation		 3,074 3,126 3,139 3,208 3,269 3,297 3,448 3,662 3,907 4,225 4,557
Total Noncurrent Assets		 6,310 6,532 6,900 7,221 7,227 6,995 7,085 7,647 9,136 8,860 8,128
Goodwill		 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362 4,362
Intangible Assets		 152 140 143 138 223 231 230 229 257 263 248
Noncurrent Deferred & Refundable Income Taxes		 473 486 537 632 757 821 905 941 936 1,030 1,096
Employee Benefit Assets		 188 189 183 166 173 169 167 184 233 240 253
Other Noncurrent Operating Assets		 1,135 1,355 1,675 1,923 1,712 1,412 1,421 1,931 3,348 2,965 2,169
Total Liabilities & Shareholders' Equity		 27,207 29,220 30,939 31,638 32,348 34,885 35,048 35,321 35,509 33,757 34,933
Total Liabilities		 12,630 13,977 14,999 15,007 15,451 17,902 17,834 18,053 18,606 17,351 18,530
Total Current Liabilities		 2,985 2,904 2,711 2,652 3,320 3,553 3,637 3,686 3,643 2,489 2,492
Short-Term Debt		 500 500 299 300 599 1,349 1,049 1,049 750 0.00 0.00
Accounts Payable		 851 952 923 713 802 551 858 794 820 866 881
Current Deferred & Payable Income Tax Liabilities		 189 372 121 108 172 378 178 108 159 284 53
Current Employee Benefit Liabilities		 799 394 561 707 836 399 569 721 839 418 595
Other Current Liabilities		 646 686 807 824 911 876 983 1,014 1,075 921 963
Total Noncurrent Liabilities		 9,645 11,073 12,288 12,355 12,131 14,349 14,197 14,367 14,963 14,862 16,038
Long-Term Debt		 8,235 9,626 10,920 10,922 10,624 12,840 12,842 12,844 12,846 12,848 14,043
Noncurrent Deferred & Payable Income Tax Liabilities		 66 73 69 66 63 55 55 54 53 56 63
Noncurrent Employee Benefit Liabilities		 118 123 127 141 108 111 113 117 110 115 122
Other Noncurrent Operating Liabilities		 1,226 1,251 1,172 1,226 1,336 1,343 1,187 1,352 1,954 1,843 1,810
Total Equity & Noncontrolling Interests		 14,577 15,243 15,940 16,631 16,897 16,983 17,214 17,268 16,903 16,406 16,403
Total Preferred & Common Equity		 14,577 15,243 15,940 16,631 16,897 16,983 17,214 17,268 16,903 16,406 16,403
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 14,577 15,243 15,940 16,631 16,897 16,983 17,214 17,268 16,903 16,406 16,403
Common Stock		 4,692 4,757 4,904 5,021 5,103 5,180 5,407 5,554 5,676 5,799 5,986
Retained Earnings		 50,353 50,930 51,522 52,098 52,283 52,199 52,135 52,304 52,262 52,196 52,249
Treasury Stock		 -40,214 -40,192 -40,240 -40,253 -40,284 -40,193 -40,128 -40,395 -40,895 -41,442 -41,676
Accumulated Other Comprehensive Income / (Loss)		 -254 -252 -246 -235 -205 -203 -200 -195 -140 -147 -156

Annual Metrics And Ratios for Texas Instruments

This table displays calculated financial ratios and metrics derived from Texas Instruments' official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 6.88% -0.35% 2.85% 11.90% 5.50% -8.88% 0.54% 26.85% 9.18% -12.53% -10.72%
EBITDA Growth		 25.37% 4.64% 9.67% 18.39% 9.95% -10.52% 3.61% 39.70% 11.61% -19.74% -16.29%
EBIT Growth		 39.28% 8.52% 16.35% 22.91% 10.60% -13.40% 5.24% 46.66% 12.56% -24.16% -23.29%
NOPAT Growth		 29.28% 6.50% 15.66% 4.05% 52.09% -10.53% 9.34% 42.41% 13.31% -27.25% -25.24%
Net Income Growth		 30.48% 5.85% 20.40% 2.42% 51.55% -10.09% 11.52% 38.86% 12.61% -25.59% -26.28%
EPS Growth		 34.56% 9.73% 23.40% 3.74% 54.85% -6.26% 13.93% 38.36% 13.92% -24.87% -26.45%
Operating Cash Flow Growth		 19.80% 8.46% 4.94% 16.23% 34.05% -7.51% -7.67% 42.63% -0.41% -26.38% -1.59%
Free Cash Flow Firm Growth		 27.72% 4.29% 3.26% 14.53% 30.65% -2.35% -8.64% 15.73% 0.79% -80.89% 26.63%
Invested Capital Growth		 -5.57% -5.59% -2.54% -6.57% -1.02% -5.79% 4.37% 20.37% 25.67% 37.21% 17.26%
Revenue Q/Q Growth		 1.87% -0.61% 1.71% 2.30% -0.21% -2.49% 5.29% 4.30% -0.80% -3.27% -0.45%
EBITDA Q/Q Growth		 8.22% 0.15% 5.69% 0.74% -0.09% -3.29% 10.19% 5.31% -2.05% -5.33% -0.78%
EBIT Q/Q Growth		 11.30% 1.22% 7.63% 0.90% -0.47% -3.86% 12.16% 6.27% -2.71% -6.96% -2.57%
NOPAT Q/Q Growth		 12.54% 1.24% 1.49% -13.48% 19.11% -3.60% 10.47% 8.09% -2.23% -8.68% -2.77%
Net Income Q/Q Growth		 12.52% 0.37% 6.24% -16.03% 19.10% -3.26% 12.42% 6.15% -1.97% -8.32% -3.34%
EPS Q/Q Growth		 13.22% 1.81% 6.75% -15.65% 19.44% -2.42% 12.64% 6.03% -1.36% -8.30% -3.53%
Operating Cash Flow Q/Q Growth		 6.15% 2.93% -3.59% 11.24% 3.10% -5.55% 6.43% 2.72% -3.49% -1.80% 1.19%
Free Cash Flow Firm Q/Q Growth		 8.80% 2.97% -7.35% 11.44% 5.96% -6.75% 5.42% -11.73% 2.31% -24.14% -0.48%
Invested Capital Q/Q Growth		 -3.89% -4.70% -1.61% -10.97% -6.02% -4.22% -1.46% 12.14% 6.67% 3.39% 2.28%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 56.93% 58.27% 61.76% 64.26% 65.11% 63.71% 64.10% 67.47% 68.76% 62.90% 58.14%
EBITDA Margin		 39.85% 41.84% 44.61% 47.20% 49.20% 48.31% 49.78% 54.82% 56.05% 51.42% 48.21%
Operating Margin		 30.26% 33.25% 36.31% 40.66% 42.53% 39.79% 40.76% 48.84% 50.63% 41.85% 34.94%
EBIT Margin		 30.42% 33.12% 37.47% 41.16% 43.15% 41.01% 42.92% 49.62% 51.16% 44.36% 38.11%
Profit (Net Income) Margin		 21.63% 22.97% 26.89% 24.61% 35.35% 34.88% 38.69% 42.35% 43.68% 37.16% 30.68%
Tax Burden Percent		 72.82% 70.83% 72.92% 60.56% 83.46% 87.59% 92.99% 87.11% 87.21% 87.76% 88.01%
Interest Burden Percent		 97.63% 97.91% 98.40% 98.73% 98.16% 97.12% 96.94% 97.98% 97.91% 95.46% 91.48%
Effective Tax Rate		 27.18% 29.17% 27.08% 39.44% 16.54% 12.41% 7.01% 12.89% 12.79% 12.24% 11.99%
Return on Invested Capital (ROIC)		 24.80% 27.98% 33.74% 36.78% 58.19% 53.90% 59.44% 75.22% 69.14% 38.08% 22.65%
ROIC Less NNEP Spread (ROIC-NNEP)		 19.43% 18.27% 53.10% 37.24% 117.49% 55.15% 125.55% 79.26% 77.23% 44.67% 22.41%
Return on Net Nonoperating Assets (RNNOA)		 1.81% 1.39% 1.47% -1.39% -0.46% 2.16% 2.40% -6.22% -6.45% 3.29% 5.74%
Return on Equity (ROE)		 26.62% 29.37% 35.21% 35.39% 57.73% 56.05% 61.84% 69.00% 62.69% 41.37% 28.40%
Cash Return on Invested Capital (CROIC)		 30.53% 33.73% 36.32% 43.56% 59.22% 59.86% 55.17% 56.73% 46.39% 6.71% 6.76%
Operating Return on Assets (OROA)		 21.86% 25.63% 30.68% 36.15% 39.17% 33.55% 33.22% 41.35% 39.50% 26.10% 17.57%
Return on Assets (ROA)		 15.54% 17.77% 22.01% 21.61% 32.09% 28.54% 29.94% 35.29% 33.73% 21.86% 14.14%
Return on Common Equity (ROCE)		 26.62% 29.37% 35.21% 35.39% 57.73% 56.05% 61.84% 69.00% 62.69% 41.37% 28.40%
Return on Equity Simple (ROE_SIMPLE)		 27.15% 30.02% 34.33% 35.62% 62.04% 56.33% 60.90% 58.27% 60.02% 38.53% 28.39%
Net Operating Profit after Tax (NOPAT)		 2,874 3,061 3,540 3,684 5,603 5,013 5,481 7,805 8,843 6,434 4,810
NOPAT Margin		 22.03% 23.55% 26.48% 24.62% 35.50% 34.85% 37.90% 42.55% 44.15% 36.72% 30.75%
Net Nonoperating Expense Percent (NNEP)		 5.37% 9.71% -19.36% -0.47% -59.30% -1.25% -66.11% -4.04% -8.08% -6.59% 0.24%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - 37.93% 22.88% 15.77%
Cost of Revenue to Revenue		 43.07% 41.73% 38.24% 35.74% 34.89% 36.29% 35.90% 32.53% 31.24% 37.10% 41.86%
SG&A Expenses to Revenue		 14.13% 13.29% 13.03% 11.32% 10.67% 11.44% 11.39% 9.38% 8.51% 10.42% 11.47%
R&D to Revenue		 10.41% 9.75% 10.14% 10.08% 9.88% 10.73% 10.58% 8.47% 8.34% 10.63% 12.52%
Operating Expenses to Revenue		 26.68% 25.02% 25.45% 23.60% 22.58% 23.92% 23.34% 18.62% 18.13% 21.05% 23.20%
Earnings before Interest and Taxes (EBIT)		 3,968 4,306 5,010 6,158 6,811 5,898 6,207 9,103 10,246 7,771 5,961
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 5,198 5,439 5,965 7,062 7,765 6,948 7,199 10,057 11,225 9,009 7,541
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 4.18 4.41 5.64 8.27 8.60 11.79 14.79 12.05 9.63 8.84 10.05
Price to Tangible Book Value (P/TBV)		 10.74 11.09 12.32 17.38 19.75 25.40 28.88 18.08 13.94 12.14 13.82
Price to Revenue (P/Rev)		 3.33 3.37 4.42 5.71 4.90 7.30 9.39 8.76 7.01 8.53 10.86
Price to Earnings (P/E)		 15.63 14.90 16.63 23.42 13.96 21.07 24.40 20.76 16.11 23.07 35.56
Dividend Yield		 3.02% 3.24% 2.77% 2.44% 3.27% 2.86% 2.51% 2.42% 3.03% 3.05% 2.83%
Earnings Yield		 6.40% 6.71% 6.01% 4.27% 7.16% 4.75% 4.10% 4.82% 6.21% 4.33% 2.81%
Enterprise Value to Invested Capital (EV/IC)		 3.93 4.19 5.69 8.76 8.14 11.65 14.45 13.99 9.83 7.78 7.67
Enterprise Value to Revenue (EV/Rev)		 3.39 3.43 4.41 5.67 4.94 7.31 9.41 8.65 6.99 8.68 11.24
Enterprise Value to EBITDA (EV/EBITDA)		 8.52 8.19 9.88 12.01 10.03 15.13 18.90 15.77 12.47 16.88 23.31
Enterprise Value to EBIT (EV/EBIT)		 11.16 10.34 11.77 13.77 11.44 17.83 21.92 17.43 13.66 19.57 29.49
Enterprise Value to NOPAT (EV/NOPAT)		 15.41 14.55 16.65 23.02 13.91 20.98 24.83 20.32 15.83 23.64 36.55
Enterprise Value to Operating Cash Flow (EV/OCF)		 10.92 10.13 12.78 15.82 10.84 15.81 22.16 18.12 16.05 23.69 27.83
Enterprise Value to Free Cash Flow (EV/FCFF)		 12.51 12.07 15.47 19.44 13.67 18.89 26.75 26.95 23.59 134.14 122.47
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.45 0.41 0.34 0.39 0.56 0.65 0.74 0.58 0.60 0.66 0.80
Long-Term Debt to Equity		 0.35 0.31 0.28 0.35 0.48 0.60 0.68 0.54 0.56 0.63 0.76
Financial Leverage		 0.09 0.08 0.03 -0.04 0.00 0.04 0.02 -0.08 -0.08 0.07 0.26
Leverage Ratio		 1.71 1.65 1.60 1.64 1.80 1.96 2.07 1.96 1.86 1.89 2.01
Compound Leverage Factor		 1.67 1.62 1.57 1.62 1.77 1.91 2.00 1.92 1.82 1.81 1.84
Debt to Total Capital		 30.83% 29.29% 25.63% 28.29% 36.04% 39.45% 42.53% 36.73% 37.47% 39.91% 44.58%
Short-Term Debt to Total Capital		 6.66% 7.11% 4.48% 3.47% 5.33% 3.40% 3.44% 2.37% 2.14% 2.13% 2.46%
Long-Term Debt to Total Capital		 24.17% 22.18% 21.15% 24.82% 30.71% 36.05% 39.09% 34.36% 35.33% 37.78% 42.12%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 69.17% 70.71% 74.37% 71.72% 63.96% 60.55% 57.47% 63.27% 62.53% 60.09% 55.42%
Debt to EBITDA		 0.89 0.76 0.61 0.58 0.65 0.84 0.94 0.77 0.78 1.25 1.80
Net Debt to EBITDA		 0.17 0.13 -0.02 -0.09 0.08 0.02 0.03 -0.20 -0.03 0.29 0.80
Long-Term Debt to EBITDA		 0.70 0.57 0.50 0.51 0.56 0.76 0.87 0.72 0.73 1.18 1.70
Debt to NOPAT		 1.61 1.35 1.02 1.11 0.90 1.16 1.24 0.99 0.99 1.74 2.83
Net Debt to NOPAT		 0.30 0.22 -0.03 -0.18 0.10 0.02 0.04 -0.26 -0.04 0.41 1.25
Long-Term Debt to NOPAT		 1.26 1.02 0.84 0.97 0.77 1.06 1.14 0.93 0.93 1.65 2.67
Altman Z-Score		 7.95 8.89 10.97 12.21 11.42 12.34 13.35 13.60 11.72 9.84 8.92
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.79 2.77 3.29 3.87 3.27 4.13 4.28 5.33 4.70 4.55 4.12
Quick Ratio		 1.80 1.72 2.10 2.55 2.20 3.04 3.34 4.45 3.67 3.12 2.55
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 3,538 3,690 3,810 4,364 5,702 5,568 5,087 5,887 5,933 1,134 1,436
Operating Cash Flow to CapEx		 1,668.31% 997.05% 868.93% 818.78% 640.73% 813.83% 951.78% 366.82% 312.10% 126.68% 136.61%
Free Cash Flow to Firm to Interest Expense		 37.64 41.00 47.63 55.95 45.61 32.75 26.77 31.99 27.73 3.21 2.83
Operating Cash Flow to Interest Expense		 43.13 48.86 57.68 68.76 57.51 39.11 32.31 47.59 40.75 18.19 12.44
Operating Cash Flow Less CapEx to Interest Expense		 40.54 43.96 51.04 60.36 48.54 34.31 28.92 34.61 27.69 3.83 3.33
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.72 0.77 0.82 0.88 0.91 0.82 0.77 0.83 0.77 0.59 0.46
Accounts Receivable Turnover		 10.65 10.78 11.00 11.76 12.70 12.61 11.62 11.78 11.14 9.52 8.92
Inventory Turnover		 3.20 3.12 2.94 2.85 2.64 2.47 2.62 3.09 2.68 1.92 1.54
Fixed Asset Turnover		 4.18 4.78 5.23 5.78 5.40 4.44 4.40 4.36 3.33 2.08 1.47
Accounts Payable Turnover		 13.08 13.18 13.08 12.41 11.67 12.05 12.93 12.11 8.80 7.86 8.07
Days Sales Outstanding (DSO)		 34.26 33.85 33.20 31.04 28.73 28.94 31.40 30.99 32.77 38.36 40.91
Days Inventory Outstanding (DIO)		 114.18 116.90 124.25 127.89 138.32 147.50 139.05 118.19 136.12 189.69 237.67
Days Payable Outstanding (DPO)		 27.90 27.69 27.91 29.42 31.28 30.28 28.23 30.15 41.48 46.41 45.21
Cash Conversion Cycle (CCC)		 120.54 123.06 129.53 129.51 135.77 146.16 142.23 119.03 127.42 181.63 233.36
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 11,256 10,627 10,357 9,677 9,578 9,023 9,417 11,335 14,245 19,545 22,919
Invested Capital Turnover		 1.13 1.19 1.27 1.49 1.64 1.55 1.57 1.77 1.57 1.04 0.74
Increase / (Decrease) in Invested Capital		 -664 -629 -270 -680 -99 -555 394 1,918 2,910 5,300 3,374
Enterprise Value (EV)		 44,280 44,534 58,954 84,816 77,917 105,150 136,070 158,627 139,990 152,067 175,810
Market Capitalization		 43,414 43,853 59,070 85,476 77,333 105,034 135,840 160,625 140,322 149,419 169,794
Book Value per Share		 $9.84 $9.80 $10.48 $10.49 $9.36 $9.53 $10.01 $14.44 $16.06 $18.60 $18.53
Tangible Book Value per Share		 $3.83 $3.90 $4.80 $4.99 $4.08 $4.42 $5.12 $9.62 $11.09 $13.56 $13.47
Total Capital		 15,021 14,066 14,082 14,414 14,062 14,710 15,985 21,074 23,312 28,120 30,499
Total Debt		 4,631 4,120 3,609 4,077 5,068 5,803 6,798 7,741 8,735 11,223 13,596
Total Long-Term Debt		 3,630 3,120 2,978 3,577 4,319 5,303 6,248 7,241 8,235 10,624 12,846
Net Debt		 866 681 -116 -660 584 116 230 -1,998 -332 2,648 6,016
Capital Expenditures (CapEx)		 243 441 531 655 1,122 817 645 2,387 2,794 5,068 4,625
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 2,223 2,301 2,334 2,507 2,139 1,751 1,831 1,877 2,469 3,826 4,553
Debt-free Net Working Capital (DFNWC)		 5,764 5,519 5,824 6,976 6,372 7,138 8,399 11,616 11,536 12,401 12,133
Net Working Capital (NWC)		 4,763 4,519 5,193 6,476 5,623 6,638 7,849 11,116 11,036 11,802 11,383
Net Nonoperating Expense (NNE)		 53 75 -55 1.82 23 -4.38 -114 36 94 -76 11
Net Nonoperating Obligations (NNO)		 866 681 -116 -660 584 116 230 -1,998 -332 2,648 6,016
Total Depreciation and Amortization (D&A)		 1,230 1,133 955 904 954 1,050 992 954 979 1,238 1,580
Debt-free, Cash-free Net Working Capital to Revenue		 17.04% 17.70% 17.46% 16.76% 13.55% 12.17% 12.66% 10.23% 12.33% 21.84% 29.11%
Debt-free Net Working Capital to Revenue		 44.19% 42.45% 43.56% 46.63% 40.37% 49.63% 58.08% 63.32% 57.60% 70.79% 77.57%
Net Working Capital to Revenue		 36.51% 34.76% 38.84% 43.29% 35.62% 46.15% 54.28% 60.60% 55.10% 67.37% 72.78%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $5.33 $6.05 $8.38 $9.51 $7.13 $5.24
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 0.00 0.00 0.00 936M 921M 923M 916M 908M 912M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $5.24 $5.97 $8.26 $9.41 $7.07 $5.20
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 0.00 0.00 0.00 952M 933M 936M 926M 916M 919M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 0.00 0.00 0.00 933.98M 920.24M 923.55M 906.21M 909.29M 910.33M
Normalized Net Operating Profit after Tax (NOPAT)		 3,077 3,244 3,762 3,883 5,870 4,981 5,481 7,805 9,067 6,434 4,700
Normalized NOPAT Margin		 23.59% 24.95% 28.14% 25.95% 37.19% 34.63% 37.90% 42.55% 45.27% 36.72% 30.05%
Pre Tax Income Margin		 29.70% 32.43% 36.87% 40.64% 42.36% 39.82% 41.61% 48.62% 50.09% 42.34% 34.86%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 42.21 47.84 62.63 78.95 54.49 34.69 32.67 49.47 47.88 22.01 11.73
NOPAT to Interest Expense		 30.58 34.01 44.25 47.23 44.82 29.49 28.85 42.42 41.32 18.23 9.47
EBIT Less CapEx to Interest Expense		 39.63 42.94 55.99 70.55 45.51 29.89 29.27 36.50 34.82 7.66 2.63
NOPAT Less CapEx to Interest Expense		 27.99 29.11 37.62 38.83 35.84 24.68 25.45 29.44 28.27 3.87 0.36
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 46.90% 48.36% 45.79% 57.14% 45.79% 59.96% 61.23% 50.02% 49.11% 70.00% 99.92%
Augmented Payout Ratio		 147.25% 140.15% 105.09% 126.56% 137.19% 118.96% 106.86% 56.80% 90.43% 74.50% 119.27%

Quarterly Metrics And Ratios for Texas Instruments

This table displays calculated financial ratios and metrics derived from Texas Instruments' official financial filings.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -3.35% -10.72% -13.07% -13.53% -12.70% -16.40% -15.65% -8.41% -1.72% 11.14% 16.38%
EBITDA Growth		 -8.62% -17.80% -19.49% -21.29% -20.36% -22.83% -26.43% -10.81% -2.98% 4.35% 18.93%
EBIT Growth		 -11.35% -21.88% -23.41% -25.49% -26.09% -30.04% -34.10% -16.58% -9.54% -0.35% 16.91%
NOPAT Growth		 -9.32% -23.99% -27.10% -27.24% -31.09% -35.26% -33.50% -19.04% -10.07% 11.31% 21.42%
Net Income Growth		 -8.23% -22.40% -24.84% -25.53% -30.12% -35.30% -34.55% -20.30% -12.11% 6.70% 14.91%
EPS Growth		 -5.73% -21.28% -23.67% -25.10% -29.91% -35.14% -34.76% -20.54% -12.67% 6.67% 15.57%
Operating Cash Flow Growth		 -13.36% -45.90% -20.87% -29.97% -5.78% -12.33% 12.29% -10.58% 3.85% -16.52% 18.40%
Free Cash Flow Firm Growth		 -468.97% -7,598.53% -387.05% -314.32% -319.46% -75.87% 9.44% 44.63% 45.39% 41.74% 14.23%
Invested Capital Growth		 25.67% 32.60% 35.97% 41.57% 37.21% 31.31% 21.64% 18.53% 17.26% 16.70% 17.14%
Revenue Q/Q Growth		 -10.89% -6.23% 3.47% 0.02% -10.04% -10.20% 4.40% 8.61% -3.47% 1.55% 9.31%
EBITDA Q/Q Growth		 -16.25% -7.83% 4.18% -2.13% -15.26% -10.69% -0.68% 18.65% -7.81% -3.95% 13.20%
EBIT Q/Q Growth		 -17.85% -9.56% 3.82% -3.40% -18.51% -14.40% -2.20% 22.28% -11.63% -5.71% 14.74%
NOPAT Q/Q Growth		 -14.80% -13.84% -0.07% -0.82% -19.30% -19.05% 2.63% 20.76% -10.36% 0.20% 11.94%
Net Income Q/Q Growth		 -14.51% -12.95% 0.82% -0.75% -19.78% -19.40% 1.99% 20.85% -11.53% -2.16% 9.84%
EPS Q/Q Growth		 -13.36% -13.55% 1.08% -1.07% -18.92% -20.00% 1.67% 20.49% -10.88% -2.29% 10.16%
Operating Cash Flow Q/Q Growth		 -26.18% -43.19% 20.60% 38.46% -0.67% -47.14% 54.47% 10.25% 15.36% -57.51% 119.08%
Free Cash Flow Firm Q/Q Growth		 -0.66% -133.29% -35.09% -30.62% -1.90% 2.19% 30.44% 20.14% -0.52% -4.35% -2.40%
Invested Capital Q/Q Growth		 6.67% 11.08% 11.27% 7.37% 3.39% 6.31% 3.07% 4.63% 2.28% 5.80% 3.46%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 66.10% 65.38% 64.22% 62.11% 59.63% 57.22% 57.85% 59.60% 57.75% 56.84% 57.89%
EBITDA Margin		 53.32% 52.41% 52.77% 51.63% 48.64% 48.37% 46.02% 50.28% 48.02% 45.42% 47.03%
Operating Margin		 46.60% 44.17% 43.52% 41.75% 37.60% 35.13% 32.65% 37.44% 34.36% 32.54% 35.14%
EBIT Margin		 47.69% 45.99% 46.15% 44.57% 40.37% 38.49% 36.05% 40.59% 37.16% 34.50% 36.22%
Profit (Net Income) Margin		 42.01% 39.00% 38.00% 37.71% 33.63% 30.18% 29.49% 32.81% 30.07% 28.98% 29.11%
Tax Burden Percent		 90.54% 87.77% 86.01% 88.92% 88.57% 85.46% 90.38% 87.64% 88.67% 92.40% 87.62%
Interest Burden Percent		 97.31% 96.62% 95.74% 95.15% 94.05% 91.77% 90.49% 92.23% 91.27% 90.88% 91.74%
Effective Tax Rate		 9.46% 12.23% 13.99% 11.08% 11.43% 14.54% 9.62% 12.36% 11.33% 7.60% 12.38%
Return on Invested Capital (ROIC)		 66.06% 54.47% 46.12% 41.68% 34.53% 27.56% 24.34% 24.96% 22.45% 21.43% 22.08%
ROIC Less NNEP Spread (ROIC-NNEP)		 66.76% 53.07% 55.97% 46.44% 35.68% 27.83% 24.31% 24.96% 22.08% 20.67% 20.92%
Return on Net Nonoperating Assets (RNNOA)		 -5.57% -2.72% 0.98% 1.67% 2.63% 3.78% 4.30% 5.46% 5.66% 7.21% 8.02%
Return on Equity (ROE)		 60.49% 51.74% 47.09% 43.36% 37.16% 31.34% 28.64% 30.41% 28.11% 28.64% 30.10%
Cash Return on Invested Capital (CROIC)		 46.39% 31.83% 19.75% 9.26% 6.71% 4.81% 7.47% 6.98% 6.76% 6.50% 6.47%
Operating Return on Assets (OROA)		 36.82% 32.92% 31.21% 27.98% 23.75% 20.17% 17.58% 19.05% 17.13% 16.13% 17.26%
Return on Assets (ROA)		 32.44% 27.92% 25.70% 23.68% 19.78% 15.82% 14.38% 15.40% 13.86% 13.55% 13.87%
Return on Common Equity (ROCE)		 60.49% 51.74% 47.09% 43.36% 37.16% 31.34% 28.64% 30.41% 28.11% 28.64% 30.10%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 54.16% 48.22% 42.70% 0.00% 34.78% 30.86% 28.75% 0.00% 29.70% 0.00%
Net Operating Profit after Tax (NOPAT)		 1,970 1,697 1,696 1,682 1,358 1,099 1,128 1,362 1,221 1,223 1,369
NOPAT Margin		 42.19% 38.76% 37.44% 37.12% 33.30% 30.02% 29.51% 32.81% 30.47% 30.07% 30.79%
Net Nonoperating Expense Percent (NNEP)		 -0.70% 1.40% -9.85% -4.76% -1.15% -0.27% 0.03% 0.00% 0.37% 0.76% 1.16%
Return On Investment Capital (ROIC_SIMPLE)		 8.45% - - - 4.83% - - - 4.00% 4.18% 4.50%
Cost of Revenue to Revenue		 33.90% 34.62% 35.78% 37.89% 40.37% 42.78% 42.15% 40.40% 42.25% 43.16% 42.11%
SG&A Expenses to Revenue		 4.71% 10.82% 10.17% 9.97% 10.74% 12.43% 12.17% 10.31% 11.13% 11.60% 10.90%
R&D to Revenue		 9.29% 10.39% 10.53% 10.39% 11.28% 13.06% 13.03% 11.85% 12.25% 12.71% 11.85%
Operating Expenses to Revenue		 19.51% 21.21% 20.70% 20.37% 22.03% 22.10% 25.20% 22.16% 23.38% 24.31% 22.75%
Earnings before Interest and Taxes (EBIT)		 2,227 2,014 2,091 2,020 1,646 1,409 1,378 1,685 1,489 1,404 1,611
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 2,490 2,295 2,391 2,340 1,983 1,771 1,759 2,087 1,924 1,848 2,092
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 9.63 10.57 9.87 8.42 8.84 9.19 10.22 10.92 10.05 9.97 11.50
Price to Tangible Book Value (P/TBV)		 13.94 15.00 13.76 11.54 12.14 12.60 13.94 14.88 13.82 13.89 15.99
Price to Revenue (P/Rev)		 7.01 8.26 8.36 7.73 8.53 9.29 10.94 12.00 10.86 10.19 11.31
Price to Earnings (P/E)		 16.11 19.60 20.57 19.82 23.07 26.55 33.30 38.17 35.56 33.74 37.61
Dividend Yield		 3.03% 2.69% 2.81% 3.22% 3.05% 2.96% 2.66% 2.52% 2.83% 2.96% 2.59%
Earnings Yield		 6.21% 5.10% 4.86% 5.05% 4.33% 3.77% 3.00% 2.62% 2.81% 2.96% 2.66%
Enterprise Value to Invested Capital (EV/IC)		 9.83 10.22 9.03 7.53 7.78 7.69 8.41 8.65 7.67 7.07 7.86
Enterprise Value to Revenue (EV/Rev)		 6.99 8.29 8.45 7.86 8.68 9.52 11.20 12.33 11.24 10.68 11.83
Enterprise Value to EBITDA (EV/EBITDA)		 12.47 15.07 15.67 14.95 16.88 18.84 22.94 25.49 23.31 22.50 24.81
Enterprise Value to EBIT (EV/EBIT)		 13.66 16.70 17.59 17.04 19.57 22.31 27.92 31.67 29.49 28.78 31.88
Enterprise Value to NOPAT (EV/NOPAT)		 15.83 19.46 20.72 20.20 23.64 27.40 34.21 39.17 36.55 34.75 38.12
Enterprise Value to Operating Cash Flow (EV/OCF)		 16.05 20.90 21.59 21.76 23.69 25.47 27.94 31.03 27.83 27.87 30.64
Enterprise Value to Free Cash Flow (EV/FCFF)		 23.59 36.60 52.70 95.22 134.14 181.58 123.67 134.31 122.47 117.17 131.07
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.60 0.66 0.70 0.67 0.66 0.84 0.81 0.80 0.80 0.78 0.86
Long-Term Debt to Equity		 0.56 0.63 0.69 0.66 0.63 0.76 0.75 0.74 0.76 0.78 0.86
Financial Leverage		 -0.08 -0.05 0.02 0.04 0.07 0.14 0.18 0.22 0.26 0.35 0.38
Leverage Ratio		 1.86 1.86 1.85 1.85 1.89 1.99 1.99 1.98 2.01 2.06 2.08
Compound Leverage Factor		 1.81 1.80 1.77 1.76 1.78 1.83 1.80 1.82 1.83 1.87 1.91
Debt to Total Capital		 37.47% 39.91% 41.31% 40.29% 39.91% 45.52% 44.66% 44.58% 44.58% 43.92% 46.12%
Short-Term Debt to Total Capital		 2.14% 1.97% 1.10% 1.08% 2.13% 4.33% 3.37% 3.37% 2.46% 0.00% 0.00%
Long-Term Debt to Total Capital		 35.33% 37.94% 40.21% 39.21% 37.78% 41.19% 41.29% 41.22% 42.12% 43.92% 46.12%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 62.53% 60.09% 58.69% 59.71% 60.09% 54.48% 55.34% 55.42% 55.42% 56.08% 53.88%
Debt to EBITDA		 0.78 0.94 1.11 1.18 1.25 1.67 1.77 1.83 1.80 1.69 1.77
Net Debt to EBITDA		 -0.03 0.05 0.16 0.24 0.29 0.45 0.54 0.68 0.80 1.03 1.09
Long-Term Debt to EBITDA		 0.73 0.90 1.08 1.15 1.18 1.51 1.64 1.69 1.70 1.69 1.77
Debt to NOPAT		 0.99 1.22 1.46 1.59 1.74 2.43 2.64 2.81 2.83 2.60 2.71
Net Debt to NOPAT		 -0.04 0.07 0.22 0.32 0.41 0.65 0.80 1.04 1.25 1.59 1.68
Long-Term Debt to NOPAT		 0.93 1.16 1.42 1.55 1.65 2.20 2.44 2.60 2.67 2.60 2.71
Altman Z-Score		 10.75 10.75 9.95 9.16 9.21 8.42 9.04 9.36 8.50 8.81 9.24
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 4.70 5.17 5.72 5.69 4.55 4.91 4.62 4.31 4.12 5.26 5.81
Quick Ratio		 3.67 3.93 4.24 4.12 3.12 3.40 3.13 2.88 2.55 2.76 2.93
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -940 -2,193 -2,962 -3,869 -3,942 -3,856 -2,682 -2,142 -2,153 -2,247 -2,301
Operating Cash Flow to CapEx		 211.17% 118.25% 96.82% 129.65% 167.60% 96.31% 147.93% 131.61% 167.76% 75.60% 142.53%
Free Cash Flow to Firm to Interest Expense		 -15.66 -32.24 -33.28 -39.48 -40.23 -33.24 -20.47 -16.35 -16.56 -17.55 -17.30
Operating Cash Flow to Interest Expense		 34.03 17.06 15.72 19.77 19.63 8.77 11.99 13.22 15.37 6.63 13.99
Operating Cash Flow Less CapEx to Interest Expense		 17.92 2.63 -0.52 4.52 7.92 -0.34 3.89 3.18 6.21 -2.14 4.17
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.77 0.72 0.68 0.63 0.59 0.52 0.49 0.47 0.46 0.47 0.48
Accounts Receivable Turnover		 11.14 10.62 9.08 9.02 9.52 9.47 8.78 8.19 8.92 9.09 9.15
Inventory Turnover		 2.68 2.36 2.14 2.04 1.92 1.78 1.67 1.58 1.54 1.54 1.57
Fixed Asset Turnover		 3.33 2.98 2.60 2.29 2.08 1.86 1.63 1.49 1.47 1.44 1.42
Accounts Payable Turnover		 8.80 7.92 7.76 8.62 7.86 8.72 7.34 8.63 8.07 9.51 8.05
Days Sales Outstanding (DSO)		 32.77 34.36 40.20 40.47 38.36 38.54 41.59 44.58 40.91 40.15 39.89
Days Inventory Outstanding (DIO)		 136.12 154.68 170.53 178.96 189.69 205.38 218.64 230.34 237.67 237.57 232.54
Days Payable Outstanding (DPO)		 41.48 46.07 47.03 42.33 46.41 41.88 49.70 42.31 45.21 38.39 45.34
Cash Conversion Cycle (CCC)		 127.42 142.97 163.70 177.09 181.63 202.04 210.53 232.61 233.36 239.34 227.09
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 14,245 15,824 17,607 18,905 19,545 20,779 21,417 22,409 22,919 24,249 25,087
Invested Capital Turnover		 1.57 1.41 1.23 1.12 1.04 0.92 0.82 0.76 0.74 0.71 0.72
Increase / (Decrease) in Invested Capital		 2,910 3,890 4,658 5,551 5,300 4,955 3,810 3,504 3,374 3,470 3,670
Enterprise Value (EV)		 139,990 161,674 159,024 142,291 152,067 159,866 180,174 193,749 175,810 171,430 197,301
Market Capitalization		 140,322 161,093 157,357 140,017 149,419 156,070 175,971 188,608 169,794 163,587 188,617
Book Value per Share		 $16.06 $16.82 $17.56 $18.32 $18.60 $18.66 $18.91 $18.91 $18.53 $18.02 $18.06
Tangible Book Value per Share		 $11.09 $11.85 $12.60 $13.36 $13.56 $13.62 $13.86 $13.88 $13.47 $12.94 $12.98
Total Capital		 23,312 25,369 27,159 27,853 28,120 31,172 31,105 31,161 30,499 29,254 30,446
Total Debt		 8,735 10,126 11,219 11,222 11,223 14,189 13,891 13,893 13,596 12,848 14,043
Total Long-Term Debt		 8,235 9,626 10,920 10,922 10,624 12,840 12,842 12,844 12,846 12,848 14,043
Net Debt		 -332 581 1,667 2,274 2,648 3,796 4,203 5,141 6,016 7,843 8,684
Capital Expenditures (CapEx)		 967 981 1,445 1,494 1,148 1,056 1,062 1,316 1,191 1,123 1,305
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 2,469 3,074 3,550 3,797 3,826 4,851 4,513 4,483 4,553 5,592 6,633
Debt-free Net Working Capital (DFNWC)		 11,536 12,619 13,102 12,745 12,401 15,244 14,201 13,235 12,133 10,597 11,992
Net Working Capital (NWC)		 11,036 12,119 12,803 12,445 11,802 13,895 13,152 12,186 11,383 10,597 11,992
Net Nonoperating Expense (NNE)		 8.15 -11 -26 -27 -13 -5.98 0.90 0.00 16 44 74
Net Nonoperating Obligations (NNO)		 -332 581 1,667 2,274 2,648 3,796 4,203 5,141 6,016 7,843 8,684
Total Depreciation and Amortization (D&A)		 263 281 300 320 337 362 381 402 435 444 481
Debt-free, Cash-free Net Working Capital to Revenue		 12.33% 15.76% 18.86% 20.96% 21.84% 28.87% 28.05% 28.53% 29.11% 34.84% 39.78%
Debt-free Net Working Capital to Revenue		 57.60% 64.71% 69.61% 70.37% 70.79% 90.73% 88.25% 84.24% 77.57% 66.03% 71.92%
Net Working Capital to Revenue		 55.10% 62.14% 68.03% 68.71% 67.37% 82.70% 81.73% 77.56% 72.78% 66.03% 71.92%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $2.16 $1.87 $1.89 $1.87 $1.50 $1.21 $1.23 $1.48 $1.32 $1.29 $1.42
Adjusted Weighted Average Basic Shares Outstanding		 916M 907M 908M 908M 908M 910M 912M 913M 912M 910M 908M
Adjusted Diluted Earnings per Share		 $2.14 $1.85 $1.87 $1.85 $1.50 $1.20 $1.22 $1.47 $1.31 $1.28 $1.41
Adjusted Weighted Average Diluted Shares Outstanding		 926M 916M 916M 916M 916M 917M 919M 920M 919M 916M 912M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 906.21M 907.65M 907.97M 908.20M 909.29M 910.48M 913.05M 912.22M 910.33M 908.47M 909.14M
Normalized Net Operating Profit after Tax (NOPAT)		 1,970 1,697 1,696 1,682 1,358 993 1,128 1,362 1,221 1,223 1,369
Normalized NOPAT Margin		 42.19% 38.76% 37.44% 37.12% 33.30% 27.13% 29.51% 32.81% 30.47% 30.07% 30.79%
Pre Tax Income Margin		 46.40% 44.44% 44.18% 42.41% 37.97% 35.32% 32.63% 37.44% 33.92% 31.36% 33.23%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 37.12 29.62 23.49 20.61 16.80 12.15 10.52 12.86 11.45 10.97 12.11
NOPAT to Interest Expense		 32.84 24.96 19.06 17.17 13.85 9.47 8.61 10.40 9.39 9.56 10.30
EBIT Less CapEx to Interest Expense		 21.00 15.19 7.26 5.37 5.08 3.04 2.41 2.82 2.29 2.20 2.30
NOPAT Less CapEx to Interest Expense		 16.72 10.54 2.82 1.92 2.14 0.37 0.50 0.35 0.23 0.78 0.48
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 49.11% 52.80% 57.55% 63.36% 70.00% 78.13% 88.01% 95.39% 99.92% 99.53% 97.20%
Augmented Payout Ratio		 90.43% 90.70% 83.91% 78.51% 74.50% 81.40% 91.49% 104.59% 119.27% 131.93% 133.11%

Key Financial Trends

TEXAS INSTRUMENTS INC (NASDAQ: TXN) has demonstrated solid financial performance over the past four years through Q2 2025, with several positive trends as well as some areas warranting caution.

  • The company has shown consistent growth in operating revenue, rising from $3.67 billion in Q1 2024 to $4.45 billion in Q2 2025, demonstrating strong top-line momentum.
  • Net income has grown steadily from $1.1 billion in Q1 2024 to $1.295 billion in Q2 2025, improving diluted EPS from $1.20 to $1.41, reflecting profitable growth and operational efficiency.
  • Operating gross profit and operating income have increased quarter-over-quarter, for example gross profit increased from $2.31 billion in Q4 2024 to $2.58 billion in Q2 2025.
  • Robust cash flow from operating activities nearly doubled from $849 million in Q1 2025 to $1.86 billion in Q2 2025, providing ample liquidity and financial flexibility.
  • Capital expenditures remain significant, supporting future growth with $1.305 billion in property, plant, and equipment purchases in Q2 2025, up from $1.12 billion in Q1 2025.
  • Texas Instruments continues returning value to shareholders with consistent dividend payments and share repurchases, paying $1.235 billion in dividends and repurchasing $302 million of equity in Q2 2025.
  • Total shareholders’ equity remains strong at $16.4 billion as of Q2 2025, supporting a solid financial position.
  • Total assets have increased moderately from $29.2 billion in Q1 2023 to $34.9 billion in Q2 2025, indicating steady asset base expansion.
  • Total debt levels increased somewhat, with long-term debt rising to $14.04 billion as of Q2 2025 from $9.63 billion in Q1 2023, potentially impacting leverage ratios.
  • The weighted average basic and diluted shares outstanding have remained roughly steady around 900 million shares, indicating limited dilution.
  • Investing cash flows have been negative in the latest quarter ($1.335 billion outflow in Q2 2025), driven by heavy investments and purchase of investments, which may pressure free cash flow in the short term.
  • There was a decrease in total current assets from $17.45 billion in Q1 2024 to $14.48 billion in Q2 2025, primarily due to declining short-term investments, which may reduce liquidity buffers.
  • Net cash used in financing activities was $244 million in Q2 2025, mainly from repurchases and debt repayments, warranted close monitoring given rising debt levels over the period.

Summary: Texas Instruments exhibits a strong and improving revenue and profit trajectory alongside healthy cash flow generation, indicating operational strength and growth prospects. Investment in property and equipment and continued shareholder returns signal management confidence in the business outlook. However, increased debt and significant capital expenditures warrant attention for potential leverage impact. Overall, TXN’s financials reflect a well-managed company with growth and profitability momentum sustained over the past several years.

08/23/25 05:21 PMAI Generated. May Contain Errors.

Frequently Asked Questions About Texas Instruments' Financials

When does Texas Instruments' financial year end?

According to the most recent income statement we have on file, Texas Instruments' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Texas Instruments' net income changed over the last 10 years?

Texas Instruments' net income appears to be on an upward trend, with a most recent value of $4.80 billion in 2024, rising from $2.82 billion in 2014. The previous period was $6.51 billion in 2023. Find out what analysts predict for Texas Instruments in the coming months.

What is Texas Instruments' operating income?
Texas Instruments' total operating income in 2024 was $5.47 billion, based on the following breakdown:
  • Total Gross Profit: $9.09 billion
  • Total Operating Expenses: $3.63 billion
How has Texas Instruments' revenue changed over the last 10 years?

Over the last 10 years, Texas Instruments' total revenue changed from $13.05 billion in 2014 to $15.64 billion in 2024, a change of 19.9%.

How much debt does Texas Instruments have?

Texas Instruments' total liabilities were at $18.61 billion at the end of 2024, a 20.4% increase from 2023, and a 166.5% increase since 2014.

How much cash does Texas Instruments have?

In the past 10 years, Texas Instruments' cash and equivalents has ranged from $1 billion in 2015 to $4.63 billion in 2021, and is currently $3.20 billion as of their latest financial filing in 2024.

How has Texas Instruments' book value per share changed over the last 10 years?

Over the last 10 years, Texas Instruments' book value per share changed from 9.84 in 2014 to 18.53 in 2024, a change of 88.4%.


Related Companies

This page (NASDAQ:TXN) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...
Weiss Ratings | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel